SAN JOSE, Calif.--(BUSINESS WIRE)--DFINE, Inc., the developer of minimally invasive radiofrequency (RF) targeted therapies for the treatment of vertebral pathologies, today announced it will debut the STAR™ Tumor Ablation System at the Society of Interventional Radiology’s (SIR) 37th Annual Scientific Meeting in San Francisco, March 24-29 (Booth #233).
